Brief: Kintor Pharmaceutical Says A Shareholder To Sell 18.2 Mln Shares At A Price Of HK$64.50/Share
27/05/2021 02:42
May 27 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* KT INTERNATIONAL INVESTMENT TO SELL 18.2 MILLION SHARES IN
AGGREGATE AT A PRICE OF HK$64.50 PER SHARE
* INTENDS TO USE ALL OF NET PROCEEDS FROM SUBSCRIPTION FOR
DEVELOPMENT AND COMMERCIALISATION OF PROXALUTAMIDE
Source text for Eikon: ID:nHKS5YNB0t
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint